Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Harmony Biosciences Holdings, Inc. (HRMY) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Harmony Biosciences Holdings, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1802665.
Total stock buying since 2020: $12,462,475.
Total stock sales since 2020: $566,436,893.
Total stock option exercises since 2020: $13,921,380.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 142,536 | $5,378,634 | 166,008 | $2,781,645 |
| 2024 | 0 | $0 | 9,270,432 | $281,349,607 | 169,075 | $628,771 |
| 2023 | 0 | $0 | 0 | $0 | 30,000 | $0 |
| 2022 | 0 | $0 | 5,089,705 | $270,342,034 | 285,636 | $3,262,251 |
| 2021 | 0 | $0 | 242,836 | $9,366,618 | 398,222 | $7,248,713 |
| 2020 | 509,936 | $12,462,475 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 21,573 | $787,371 | 0 | $0 |
| 2025-05 | 0 | $0 | 0 | $0 | 18,750 | $0 |
| 2025-04 | 0 | $0 | 6,987 | $229,145 | 0 | $0 |
| 2025-03 | 0 | $0 | 4,869 | $160,287 | 19,869 | $40,023 |
| 2025-01 | 0 | $0 | 109,107 | $4,201,831 | 127,389 | $2,741,622 |
| 2024-11 | 0 | $0 | 9,200,000 | $278,787,600 | 0 | $0 |
| 2024-10 | 0 | $0 | 58,253 | $2,170,670 | 21,896 | $525,504 |
| 2024-09 | 0 | $0 | 200 | $8,009 | 120,200 | $4,800 |
| 2024-03 | 0 | $0 | 11,979 | $383,328 | 26,979 | $98,467 |
| 2023-03 | 0 | $0 | 0 | $0 | 30,000 | $0 |
| 2022-12 | 0 | $0 | 321,097 | $19,403,867 | 38,000 | $312,360 |
| 2022-11 | 0 | $0 | 1,721,053 | $100,266,357 | 30,000 | $246,600 |
| 2022-08 | 0 | $0 | 1,045,226 | $55,690,389 | 68,971 | $1,024,104 |
| 2022-07 | 0 | $0 | 368,407 | $20,354,814 | 0 | $0 |
| 2022-06 | 0 | $0 | 143,996 | $7,229,698 | 40,000 | $328,800 |
| 2022-04 | 0 | $0 | 308,046 | $15,850,124 | 14,471 | $347,304 |
| 2022-03 | 0 | $0 | 1,128,496 | $49,260,352 | 44,869 | $368,823 |
| 2022-02 | 0 | $0 | 18,559 | $742,662 | 14,500 | $348,000 |
| 2022-01 | 0 | $0 | 34,825 | $1,543,771 | 34,825 | $286,260 |
| 2021-12 | 0 | $0 | 53,568 | $2,107,360 | 278,222 | $6,262,314 |
| 2021-11 | 0 | $0 | 79,268 | $3,300,652 | 10,000 | $82,200 |
| 2021-10 | 0 | $0 | 20,000 | $862,949 | 20,000 | $164,400 |
| 2021-09 | 0 | $0 | 50,000 | $1,796,814 | 50,000 | $411,000 |
| 2021-08 | 0 | $0 | 24,950 | $827,543 | 24,950 | $205,088 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-15 | Kapadia Sandip (CHIEF FINANCIAL OFFICER) | Sale | 21,573 | 36.50 | 787,371 |
| 2025-05-01 | Budur Kumar (CHIEF MEDICAL OFFICER) | Option Ex | 18,750 | .00 | 0 |
| 2025-04-01 | Kapadia Sandip (CHIEF FINANCIAL OFFICER) | Sale | 6,987 | 32.80 | 229,145 |
| 2025-03-29 | Kapadia Sandip (CHIEF FINANCIAL OFFICER) | Option Ex | 15,000 | .00 | 0 |
| 2025-03-03 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Sale | 4,869 | 32.92 | 160,287 |
| 2025-03-03 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Option Ex | 4,869 | 8.22 | 40,023 |
| 2025-01-27 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Sale | 1,629 | 38.02 | 61,941 |
| 2025-01-27 | Kapadia Sandip (CHIEF FINANCIAL OFFICER) | Sale | 1,775 | 38.05 | 67,547 |
| 2025-01-24 | Budur Kumar (CHIEF MEDICAL OFFICER) | Option Ex | 2,187 | .00 | 0 |
| 2025-01-24 | Serafin Andrew (CHIEF STRATEGY OFFICER) | Option Ex | 2,500 | .00 | 0 |
| 2025-01-24 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Sale | 13,125 | 37.41 | 490,980 |
| 2025-01-24 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Option Ex | 15,812 | 15.35 | 242,635 |
| 2025-01-24 | Kapadia Sandip (CHIEF FINANCIAL OFFICER) | Option Ex | 3,812 | .00 | 0 |
| 2025-01-24 | Dayno Jeffrey M. (PRESIDENT, CEO) | Option Ex | 10,500 | .00 | 0 |
| 2025-01-21 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Sale | 1,123 | 40.00 | 44,920 |
| 2025-01-21 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Option Ex | 1,123 | 33.44 | 37,553 |
| 2025-01-21 | Kapadia Sandip (CHIEF FINANCIAL OFFICER) | Sale | 25,000 | 40.18 | 1,004,599 |
| 2025-01-21 | Kapadia Sandip (CHIEF FINANCIAL OFFICER) | Option Ex | 25,000 | 29.03 | 725,750 |
| 2025-01-21 | Dayno Jeffrey M. (PRESIDENT, CEO) | Sale | 19,293 | 40.13 | 774,247 |
| 2025-01-21 | Dayno Jeffrey M. (PRESIDENT, CEO) | Option Ex | 19,293 | 8.22 | 158,588 |
| 2025-01-16 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Sale | 29,475 | 37.41 | 1,102,807 |
| 2025-01-16 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Option Ex | 29,475 | 33.44 | 985,643 |
| 2025-01-15 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Sale | 10,507 | 37.01 | 388,843 |
| 2025-01-15 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Option Ex | 10,507 | 33.44 | 351,354 |
| 2025-01-13 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Sale | 7,180 | 37.04 | 265,947 |
| 2025-01-13 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Option Ex | 7,180 | 33.44 | 240,099 |
| 2024-11-05 | Marshman Fund Trust Ii | Sale | 600,000 | 30.30 | 18,181,800 |
| 2024-11-05 | Sabater Juan A. | Sale | 600,000 | 30.30 | 18,181,800 |
| 2024-11-01 | Marshman Fund Trust Ii | Sale | 4,000,000 | 30.30 | 121,212,000 |
| 2024-11-01 | Sabater Juan A. | Sale | 4,000,000 | 30.30 | 121,212,000 |
| 2024-10-29 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Sale | 21,496 | 40.47 | 870,029 |
| 2024-10-29 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Option Ex | 21,496 | 24.00 | 515,904 |
| 2024-10-03 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Sale | 36,357 | 35.33 | 1,284,565 |
| 2024-10-01 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Sale | 400 | 40.19 | 16,076 |
| 2024-10-01 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Option Ex | 400 | 24.00 | 9,600 |
| 2024-09-30 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Option Ex | 60,000 | .00 | 0 |
| 2024-09-30 | Kapadia Sandip (CHIEF FINANCIAL OFFICER) | Option Ex | 60,000 | .00 | 0 |
| 2024-09-27 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Sale | 200 | 40.05 | 8,009 |
| 2024-09-27 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Option Ex | 200 | 24.00 | 4,800 |
| 2024-03-29 | Kapadia Sandip (CHIEF FINANCIAL OFFICER) | Option Ex | 15,000 | .00 | 0 |
| 2024-03-15 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Sale | 11,979 | 32.00 | 383,328 |
| 2024-03-15 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Option Ex | 11,979 | 8.22 | 98,467 |
| 2023-03-29 | Kapadia Sandip (CHIEF FINANCIAL OFFICER) | Option Ex | 30,000 | .00 | 0 |
| 2022-12-14 | Wicki Andreas | Sale | 130 | 60.00 | 7,800 |
| 2022-12-13 | Wicki Andreas | Sale | 6,320 | 60.13 | 380,021 |
| 2022-12-12 | Wicki Andreas | Sale | 22,391 | 60.36 | 1,351,520 |
| 2022-12-09 | Nielsen Jack | Sale | 9,847 | 59.89 | 589,736 |
| 2022-12-08 | Nielsen Jack | Sale | 36,878 | 59.90 | 2,208,992 |
| 2022-12-07 | Nielsen Jack | Sale | 64,026 | 60.35 | 3,863,969 |
| 2022-12-05 | Wicki Andreas | Sale | 77,853 | 61.23 | 4,766,939 |
| 2022-12-02 | Serafin Andrew (CHIEF STRATEGY OFFICER) | Sale | 38,000 | 60.41 | 2,295,770 |
| 2022-12-02 | Serafin Andrew (CHIEF STRATEGY OFFICER) | Option Ex | 38,000 | 8.22 | 312,360 |
| 2022-12-01 | Nielsen Jack | Sale | 65,652 | 60.00 | 3,939,120 |
| 2022-11-30 | Nielsen Jack | Sale | 42,667 | 58.93 | 2,514,366 |
| 2022-11-29 | Nielsen Jack | Sale | 21,333 | 57.82 | 1,233,474 |
| 2022-11-22 | Nielsen Jack | Sale | 31,902 | 57.60 | 1,837,555 |
| 2022-11-21 | Nielsen Jack | Sale | 24,898 | 57.08 | 1,421,177 |
| 2022-11-18 | Nielsen Jack | Sale | 20,800 | 57.00 | 1,185,600 |
| 2022-11-15 | Nielsen Jack | Sale | 188,799 | 56.80 | 10,723,782 |
| 2022-11-15 | Wicki Andreas | Sale | 10,961 | 60.10 | 658,756 |
| 2022-11-14 | Nielsen Jack | Sale | 176,001 | 58.70 | 10,331,256 |
| 2022-11-14 | Wicki Andreas | Sale | 40,317 | 59.10 | 2,382,734 |
| 2022-11-11 | Nielsen Jack | Sale | 110,400 | 57.14 | 6,308,256 |
| 2022-11-10 | Wicki Andreas | Sale | 95,242 | 58.80 | 5,600,229 |
| 2022-11-09 | Wicki Andreas | Sale | 15,301 | 58.05 | 888,223 |
| 2022-11-08 | Wicki Andreas | Sale | 18,865 | 60.01 | 1,132,088 |
| 2022-11-04 | Wicki Andreas | Sale | 157,950 | 58.81 | 9,289,039 |
| 2022-11-03 | Dayno Jeffrey M. (CHIEF MEDICAL OFFICER) | Sale | 15,000 | 60.02 | 900,330 |
| 2022-11-03 | Dayno Jeffrey M. (CHIEF MEDICAL OFFICER) | Option Ex | 15,000 | 8.22 | 123,300 |
| 2022-11-03 | Wicki Andreas | Sale | 254,141 | 59.44 | 15,106,141 |
| 2022-11-02 | Wicki Andreas | Sale | 164,676 | 58.81 | 9,684,595 |
| 2022-11-01 | Dayno Jeffrey M. (CHIEF MEDICAL OFFICER) | Sale | 15,000 | 55.10 | 826,560 |
| 2022-11-01 | Dayno Jeffrey M. (CHIEF MEDICAL OFFICER) | Option Ex | 15,000 | 8.22 | 123,300 |
| 2022-08-22 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Sale | 28,971 | 47.26 | 1,369,140 |
| 2022-08-22 | Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) | Option Ex | 28,971 | 24.00 | 695,304 |
| 2022-08-15 | Jacobs John C (PRESIDENT, CEO) | Sale | 40,000 | 51.41 | 2,056,360 |
| 2022-08-15 | Jacobs John C (PRESIDENT, CEO) | Option Ex | 40,000 | 8.22 | 328,800 |
| 2022-08-10 | Wicki Andreas | Sale | 71,447 | 52.61 | 3,758,826 |
| 2022-08-09 | Wicki Andreas | Sale | 20,745 | 53.67 | 1,113,384 |
| 2022-08-08 | Nielsen Jack | Sale | 75,000 | 53.56 | 4,017,000 |
| 2022-08-08 | Wicki Andreas | Sale | 486,360 | 53.94 | 26,234,258 |
| 2022-08-05 | Nielsen Jack | Sale | 115,000 | 52.42 | 6,028,300 |
| 2022-08-05 | Wicki Andreas | Sale | 29,482 | 52.57 | 1,549,868 |
| 2022-08-04 | Nielsen Jack | Sale | 60,000 | 52.30 | 3,138,000 |
| 2022-08-04 | Wicki Andreas | Sale | 12,640 | 52.67 | 665,748 |
| 2022-08-03 | Wicki Andreas | Sale | 30,464 | 52.90 | 1,611,545 |
| 2022-08-02 | Nielsen Jack | Sale | 75,117 | 55.22 | 4,147,960 |
| 2022-07-18 | Nielsen Jack | Sale | 40,087 | 55.19 | 2,212,401 |
| 2022-07-13 | Nielsen Jack | Sale | 5,773 | 55.04 | 317,745 |
| 2022-07-11 | Nielsen Jack | Sale | 3,058 | 55.01 | 168,220 |
| 2022-07-08 | Nielsen Jack | Sale | 7,710 | 55.07 | 424,589 |
| 2022-07-07 | Nielsen Jack | Sale | 180,838 | 56.01 | 10,128,736 |
| 2022-07-06 | Nielsen Jack | Sale | 87,417 | 55.26 | 4,830,663 |
| 2022-07-05 | Nielsen Jack | Sale | 32,486 | 52.27 | 1,698,043 |
| 2022-07-01 | Nielsen Jack | Sale | 11,038 | 52.04 | 574,417 |
| 2022-06-29 | Nielsen Jack | Sale | 3,533 | 52.20 | 184,422 |
| 2022-06-28 | Nielsen Jack | Sale | 2,726 | 52.10 | 142,024 |
| 2022-06-27 | Nielsen Jack | Sale | 86,209 | 52.37 | 4,514,765 |
| 2022-06-24 | Nielsen Jack | Sale | 11,528 | 52.06 | 600,147 |
| 2022-06-15 | Jacobs John C (President, CEO) | Sale | 15,000 | 45.76 | 686,340 |
| 2022-06-15 | Jacobs John C (President, CEO) | Option Ex | 15,000 | 8.22 | 123,300 |
| 2022-06-13 | Jacobs John C (President, CEO) | Sale | 25,000 | 44.08 | 1,102,000 |
| 2022-06-13 | Jacobs John C (President, CEO) | Option Ex | 25,000 | 8.22 | 205,500 |
| 2022-04-21 | Nielsen Jack | Sale | 6,554 | 52.19 | 342,053 |
| 2022-04-20 | Nielsen Jack | Sale | 30,177 | 52.14 | 1,573,428 |
| 2022-04-19 | Nielsen Jack | Sale | 97,886 | 52.35 | 5,124,332 |
| 2022-04-18 | Nielsen Jack | Sale | 4,195 | 52.14 | 218,727 |
| 2022-04-14 | Nielsen Jack | Sale | 13,668 | 52.08 | 711,829 |
| 2022-04-13 | Nielsen Jack | Sale | 86,206 | 51.15 | 4,409,436 |
| 2022-04-12 | Nielsen Jack | Sale | 19,955 | 50.05 | 998,747 |
| 2022-04-08 | Nielsen Jack | Sale | 5,899 | 50.09 | 295,480 |
| 2022-04-07 | Nielsen Jack | Sale | 5,266 | 50.25 | 264,616 |
| 2022-04-05 | Nielsen Jack | Sale | 20,367 | 50.25 | 1,023,441 |
| 2022-04-04 | Nielsen Jack | Sale | 1,027 | 50.00 | 51,350 |
| 2022-04-01 | Dierks Jeffrey (Chief Commercial Officer) | Sale | 14,471 | 49.61 | 717,935 |
| 2022-04-01 | Dierks Jeffrey (Chief Commercial Officer) | Option Ex | 14,471 | 24.00 | 347,304 |
| 2022-04-01 | Nielsen Jack | Sale | 2,375 | 50.00 | 118,750 |
| 2022-03-31 | Nielsen Jack | Sale | 7,165 | 50.15 | 359,324 |
| 2022-03-30 | Nielsen Jack | Sale | 27,851 | 50.24 | 1,399,234 |
| 2022-03-29 | Nielsen Jack | Sale | 35,408 | 50.89 | 1,801,913 |
| 2022-03-28 | Nielsen Jack | Sale | 42,489 | 50.82 | 2,159,290 |
| 2022-03-25 | Nielsen Jack | Sale | 36,224 | 50.24 | 1,819,893 |
| 2022-03-24 | Nielsen Jack | Sale | 18,935 | 50.12 | 949,022 |
| 2022-03-23 | Nielsen Jack | Sale | 10,783 | 50.25 | 541,845 |
| 2022-03-22 | Nielsen Jack | Sale | 6,576 | 50.13 | 329,654 |
| 2022-03-18 | Nielsen Jack | Sale | 10,285 | 50.10 | 515,278 |
| 2022-03-17 | Nielsen Jack | Sale | 5,896 | 50.05 | 295,094 |
| 2022-03-16 | Jacobs John C (President, CEO) | Sale | 15,000 | 45.32 | 679,815 |
| 2022-03-16 | Jacobs John C (President, CEO) | Option Ex | 15,000 | 8.22 | 123,300 |
| 2022-03-14 | Jacobs John C (President, CEO) | Sale | 25,000 | 42.73 | 1,068,250 |
| 2022-03-14 | Jacobs John C (President, CEO) | Option Ex | 25,000 | 8.22 | 205,500 |
| 2022-03-11 | Wicki Andreas | Sale | 70,370 | 44.14 | 3,106,131 |
| 2022-03-10 | Wicki Andreas | Sale | 75,217 | 45.80 | 3,444,938 |
| 2022-03-09 | Wicki Andreas | Sale | 140,000 | 45.49 | 6,368,600 |
| 2022-03-03 | Wicki Andreas | Sale | 175,000 | 41.01 | 7,176,750 |
| 2022-03-02 | Wicki Andreas | Sale | 328,927 | 40.52 | 13,328,122 |
| 2022-03-01 | Dierks Jeffrey (Chief Commercial Officer) | Sale | 4,869 | 40.04 | 194,959 |
| 2022-03-01 | Dierks Jeffrey (Chief Commercial Officer) | Option Ex | 4,869 | 8.22 | 40,023 |
| 2022-03-01 | Wicki Andreas | Sale | 92,501 | 40.24 | 3,722,240 |
| 2022-02-28 | Dierks Jeffrey (Chief Commercial Officer) | Sale | 10,041 | 40.00 | 401,650 |
| 2022-02-28 | Dierks Jeffrey (Chief Commercial Officer) | Option Ex | 10,041 | 24.00 | 240,984 |
| 2022-02-17 | Dierks Jeffrey (Chief Commercial Officer) | Sale | 4,259 | 40.02 | 170,423 |
| 2022-02-17 | Dierks Jeffrey (Chief Commercial Officer) | Option Ex | 200 | 24.00 | 4,800 |
| 2022-02-16 | Dierks Jeffrey (Chief Commercial Officer) | Sale | 4,259 | 40.05 | 170,589 |
| 2022-02-16 | Dierks Jeffrey (Chief Commercial Officer) | Option Ex | 4,259 | 24.00 | 102,216 |
| 2022-01-06 | Dierks Jeffrey (Chief Commercial Officer) | Sale | 6,125 | 40.45 | 247,780 |
| 2022-01-06 | Dierks Jeffrey (Chief Commercial Officer) | Option Ex | 6,125 | 8.22 | 50,347 |
| 2022-01-04 | Jacobs John C (President, CEO) | Sale | 18,053 | 45.15 | 815,056 |
| 2022-01-04 | Jacobs John C (President, CEO) | Option Ex | 18,053 | 8.22 | 148,395 |
| 2022-01-03 | Jacobs John C (President, CEO) | Sale | 10,647 | 45.17 | 480,935 |
| 2022-01-03 | Jacobs John C (President, CEO) | Option Ex | 10,647 | 8.22 | 87,518 |
| 2021-12-27 | Jacobs John C (President, CEO) | Sale | 1,300 | 45.03 | 58,539 |
| 2021-12-27 | Jacobs John C (President, CEO) | Option Ex | 1,300 | 8.22 | 10,686 |
| 2021-12-14 | Aronin Jeffrey S | Option Ex | 251,922 | 24.00 | 6,046,128 |
| 2021-12-13 | Jacobs John C (President, CEO) | Sale | 25,000 | 38.23 | 955,674 |
| 2021-12-13 | Jacobs John C (President, CEO) | Option Ex | 25,000 | 8.22 | 205,500 |
| 2021-12-10 | Wicki Andreas | Sale | 2,585 | 40.08 | 103,606 |
| 2021-12-08 | Wicki Andreas | Sale | 24,683 | 40.09 | 989,541 |
| 2021-11-17 | Wicki Andreas | Sale | 1,417 | 41.25 | 58,451 |
| 2021-11-16 | Wicki Andreas | Sale | 32,251 | 41.09 | 1,325,193 |
| 2021-11-15 | Wicki Andreas | Sale | 35,600 | 42.08 | 1,498,048 |
| 2021-11-01 | Dierks Jeffrey (Chief Commercial Officer) | Sale | 10,000 | 41.90 | 418,960 |
| 2021-11-01 | Dierks Jeffrey (Chief Commercial Officer) | Option Ex | 10,000 | 8.22 | 82,200 |
| 2021-10-19 | Dayno Jeffrey M. (Chief Medical Officer) | Sale | 18,200 | 43.45 | 790,771 |
| 2021-10-19 | Dayno Jeffrey M. (Chief Medical Officer) | Option Ex | 18,200 | 8.22 | 149,604 |
| 2021-10-06 | Dayno Jeffrey M. (Chief Medical Officer) | Sale | 1,800 | 40.10 | 72,178 |
| 2021-10-06 | Dayno Jeffrey M. (Chief Medical Officer) | Option Ex | 1,800 | 8.22 | 14,796 |
| 2021-09-13 | Jacobs John C (President, CEO) | Sale | 25,000 | 35.93 | 898,274 |
| 2021-09-13 | Jacobs John C (President, CEO) | Option Ex | 25,000 | 8.22 | 205,500 |
| 2021-09-07 | Dierks Jeffrey (Chief Commercial Officer) | Sale | 5,000 | 37.00 | 185,000 |
| 2021-09-07 | Dierks Jeffrey (Chief Commercial Officer) | Option Ex | 5,000 | 8.22 | 41,100 |
| 2021-09-07 | Dayno Jeffrey M. (Chief Medical Officer) | Sale | 10,000 | 37.58 | 375,780 |
| 2021-09-07 | Dayno Jeffrey M. (Chief Medical Officer) | Option Ex | 10,000 | 8.22 | 82,200 |
| 2021-09-01 | Dierks Jeffrey (Chief Commercial Officer) | Sale | 10,000 | 33.78 | 337,760 |
| 2021-09-01 | Dierks Jeffrey (Chief Commercial Officer) | Option Ex | 10,000 | 8.22 | 82,200 |
| 2021-08-27 | Dierks Jeffrey (Chief Commercial Officer) | Sale | 3,400 | 35.18 | 119,605 |
| 2021-08-27 | Dierks Jeffrey (Chief Commercial Officer) | Option Ex | 3,400 | 8.22 | 27,948 |
| 2021-08-27 | Dayno Jeffrey M. (Chief Medical Officer) | Sale | 7,841 | 35.16 | 275,697 |
| 2021-08-27 | Dayno Jeffrey M. (Chief Medical Officer) | Option Ex | 7,841 | 8.22 | 64,453 |
| 2021-08-26 | Dierks Jeffrey (Chief Commercial Officer) | Sale | 1,600 | 35.01 | 56,020 |
| 2021-08-26 | Dierks Jeffrey (Chief Commercial Officer) | Option Ex | 1,600 | 8.22 | 13,152 |
| 2021-08-26 | Dayno Jeffrey M. (Chief Medical Officer) | Sale | 2,159 | 35.01 | 75,582 |
| 2021-08-26 | Dayno Jeffrey M. (Chief Medical Officer) | Option Ex | 2,159 | 8.22 | 17,746 |
| 2021-08-10 | Dayno Jeffrey M. (Chief Medical Officer) | Sale | 9,950 | 30.21 | 300,639 |
| 2021-08-10 | Dayno Jeffrey M. (Chief Medical Officer) | Option Ex | 9,950 | 8.22 | 81,789 |
| 2021-07-22 | Dayno Jeffrey M. (Chief Medical Officer) | Sale | 50 | 30.00 | 1,500 |
| 2021-07-22 | Dayno Jeffrey M. (Chief Medical Officer) | Option Ex | 50 | 8.22 | 411 |
| 2021-06-15 | Dierks Jeffrey (Chief Commercial Officer) | Sale | 15,000 | 31.32 | 469,800 |
| 2021-06-15 | Dierks Jeffrey (Chief Commercial Officer) | Option Ex | 15,000 | 8.22 | 123,300 |
| 2020-08-24 | Nielsen Jack (Director) | Buy | 3,057 | 34.30 | 104,855 |
| 2020-08-21 | Marshman Fund Trust Ii (10% Owner) | Buy | 339,476 | 24.00 | 8,147,424 |
| 2020-08-21 | Nielsen Jack (Director) | Buy | 32,164 | 29.05 | 934,364 |
| 2020-08-21 | Novo Holdings A/s (10% Owner) | Buy | 132,503 | 24.00 | 3,180,072 |
| 2020-08-20 | Nielsen Jack (Director) | Buy | 2,736 | 35.00 | 95,760 |
Insider trading activities including stock purchases, stock sales, and option exercises of HRMY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Harmony Biosciences Holdings, Inc. (symbol HRMY, CIK number 1802665) see the Securities and Exchange Commission (SEC) website.